AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36038705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 5 cycles of 3 min at 80% peak oxygen uptake alternating with 3 min at 40% peak oxygen uptake
Number of subjects: 16
Study 36038705 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Steady-State Exercise (MISS) - 30 min at 60% peak oxygen uptake
Number of subjects: 16
Study 33880724 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Partial Breast Irradiation (APBI) - 3D conformal external irradiation, 3.75 Gy/fraction, twice a day, 5 fractions/week, total dose 37.5 Gy
Number of subjects: 86
Study 33880724 — intervention group
Group type: COMPARATOR
Intervention: Whole Breast Irradiation (WBI) - 3D conformal external irradiation, 2 Gy daily/fraction, 5 fractions/week, total dose 50 Gy
Number of subjects: 86
Study 33880724 — intervention group
Group type: EXPERIMENTAL
Intervention: APBI
Number of subjects: 86
Study 33880724 — intervention group
Group type: COMPARATOR
Intervention: WBI
Number of subjects: 86
Study 32492153 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol; 2000 IU/day)
Number of subjects: 25871
Study 35124517 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring flexibility (positive on the forward bending task, n = 17)
Number of subjects: 140
Study 35124517 — intervention group
Group type: COMPARATOR
Intervention: Control group (negative on the forward bending task, n = 17)
Number of subjects: 140
Study 34077499 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 175
Study 34077499 — intervention group
Group type: COMPARATOR
Intervention: Blood Glucose Meter (BGM)
Number of subjects: 175
Study 34077499 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM
Number of subjects: 175
Study 34077499 — intervention group
Group type: COMPARATOR
Intervention: BGM
Number of subjects: 175
Study 33322629 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine milk-based multicomponent fortifier and protein supplement
Number of subjects: 103
Study 33322629 — intervention group
Group type: COMPARATOR
Intervention: Donkey milk-derived multicomponent fortifier and protein supplement
Number of subjects: 103
Study 32984909 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral plus intravenous (IV) antibiotic prophylaxis (AP) - oral erythromycin 500 mg + metronidazole 500 mg a day before surgery and 1,000 mg of cephalosporin IV 30–90 min before operation
Number of subjects: 116
Study 32984909 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) antibiotic prophylaxis only
Number of subjects: 116
Study 32184315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Squad+ smartphone app
Number of subjects: 74
Study 32184315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Squad+ smartphone app with nurse support
Number of subjects: 74
Study 32184315 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 74
Study 35688408 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure with preserved ejection fraction (HFpEF)
Number of subjects: 7141
Study 35688408 — intervention group
Group type: COMPARATOR
Intervention: Heart failure with reduced ejection fraction (HFrEF)
Number of subjects: 7141
Study 34737864 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar intervention video
Number of subjects: 4013
Study 34737864 — intervention group
Group type: COMPARATOR
Intervention: Sunscreen content placebo video
Number of subjects: 4013
Study 34737864 — intervention group
Group type: COMPARATOR
Intervention: Earthquake placebo video
Number of subjects: 4013
Study 35644960 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia with 1% tetracaine
Number of subjects: 92
Study 35644960 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 92
Study 33541362 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS depression scales
Number of subjects: 651
Study 33541362 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire (PHQ) scales
Number of subjects: 651
Study 33541362 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 Mental Health scale
Number of subjects: 651
Study 35277087 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 group (0.25 mg/kg i.v. loading dose of esmolol, followed by 5 µg/kg/min infusion)
Number of subjects: 33
Study 35277087 — intervention group
Group type: EXPERIMENTAL
Intervention: E10 group (0.5 mg/kg i.v. loading dose of esmolol, followed by 10 µg/kg/min infusion)
Number of subjects: 33
Study 35277087 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 group
Number of subjects: 33
Study 35277087 — intervention group
Group type: EXPERIMENTAL
Intervention: E10 group
Number of subjects: 33
Study 34946280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentapen® syringe
Number of subjects: 178
Study 34946280 — intervention group
Group type: COMPARATOR
Intervention: Traditional syringe
Number of subjects: 178
Study 36314199 — intervention group
Group type: EXPERIMENTAL
Intervention: BetterBrains intervention
Number of subjects: 1510
Study 36314199 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1510
Study 32751812 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Games for Understanding (TGfU) intervention for six months
Number of subjects: 188
Study 32751812 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional methodologies)
Number of subjects: 188
Study 36494306 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst spinal cord stimulation (SCS)
Number of subjects: 25
Study 36494306 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency 10,000 Hz spinal cord stimulation (SCS)
Number of subjects: 25
Study 34474441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine by intravenous continuous infusion (0.25 mg/kg/h)
Number of subjects: 50
Study 34474441 — intervention group
Group type: COMPARATOR
Intervention: Ketamine by intravenous bolus (0.25 mg/kg every hour)
Number of subjects: 50
Study 34474441 — intervention group
Group type: COMPARATOR
Intervention: Ketamine by intravenous bolus
Number of subjects: 50
Study 34474441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine by intravenous continuous infusion
Number of subjects: 50
Study 34474441 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 35639525 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir (1800 mg BID on day 1, 800 mg BID on days 2-5)
Number of subjects: 827
Study 35639525 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 827
Study 35639525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 827
Study 35983527 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) prediction model
Number of subjects: 200
Study 35983527 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 200
Study 35983527 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent influencing factors of NAFLD
Number of subjects: 200
Study 36480360 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased gesture exposure through parent-directed training
Number of subjects: 81
Study 36480360 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard exposure to gestures)
Number of subjects: 81
Study 33893522 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell therapy (mesenchymal stem cells)
Number of subjects: 51
Study 33893522 — intervention group
Group type: COMPARATOR
Intervention: Core decompression alone
Number of subjects: 51
Study 33893522 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 51
Study 33231007 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy
Number of subjects: 80
Study 33231007 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 80
Study 34228877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional Candida antigen (0.3 ml injection)
Number of subjects: 80
Study 34228877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional vitamin D3 (0.6 ml, 60,000 IU injection)
Number of subjects: 80
Study 34228877 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.3 ml injection)
Number of subjects: 80
Study 32629685 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 284
Study 32629685 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 284
Study 35174790 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal (TEP) hernia repair
Number of subjects: 60
Study 35174790 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein hernia repair (LHR)
Number of subjects: 60
Study 35174790 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TEP and LHR
Number of subjects: 60
Study 32481563 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg red Korean ginseng extract per day for seven days
Number of subjects: 24
Study 36196711 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (HSS) infusion plus standard diuretics therapy (SDT)
Number of subjects: 90
Study 36196711 — intervention group
Group type: EXPERIMENTAL
Intervention: Etilefrine tablets plus standard diuretics therapy (SDT)
Number of subjects: 90
Study 36196711 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HSS infusion and etilefrine tablets plus standard diuretics therapy (SDT)
Number of subjects: 90
Study 36196711 — intervention group
Group type: COMPARATOR
Intervention: Standard diuretics therapy (SDT) alone
Number of subjects: 90
Study 34336625 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg/h)
Number of subjects: 50
Study 34336625 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard anesthesia)
Number of subjects: 50
Study 35719234 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense warm-up after foam rolling (FR)
Number of subjects: 27
Study 35719234 — intervention group
Group type: COMPARATOR
Intervention: Foam rolling without intense warm-up
Number of subjects: 27
Study 35719234 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense warm-up before foam rolling (FR)
Number of subjects: 27
Study 33887443 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote assessment strategies for physical function and physical activity
Number of subjects: 0
Study 33887443 — intervention group
Group type: COMPARATOR
Intervention: In-person assessments
Number of subjects: 0
Study 32305727 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI/bevacizumab
Number of subjects: 773
Study 32305727 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI/cetuximab
Number of subjects: 773
Study 34224871 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic urethrolysis
Number of subjects: 0
Study 34224871 — intervention group
Group type: COMPARATOR
Intervention: Vaginal approach
Number of subjects: 0
Study 36066846 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy device (cold and vibration)
Number of subjects: 60
Study 36066846 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Buzzy device)
Number of subjects: 60
Study 33632072 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress (emotionally stressful video)
Number of subjects: 37
Study 33632072 — intervention group
Group type: COMPARATOR
Intervention: Control (non-stressful video)
Number of subjects: 37
Study 33632072 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline oxytocin
Number of subjects: 37
Study 33632072 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic stress effects
Number of subjects: 37
Study 32006006 — intervention group
Group type: EXPERIMENTAL
Intervention: D46/NS2/N/ΔM2‐2‐HindIII (vaccine)
Number of subjects: 32
Study 32006006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34866258 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dextrose as first line treatment
Number of subjects: 18
Study 34866258 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-checking blood glucose concentrations after oral dextrose
Number of subjects: 18
Study 34866258 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic threshold for hypoglycaemia
Number of subjects: 18
Study 34866258 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose oxidase method of testing
Number of subjects: 18
Study 34866258 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to paediatric services or neonatal intensive care unit
Number of subjects: 18
Study 34866258 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of intravenous dextrose
Number of subjects: 18
Study 36457177 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training group (aerobic and resistance training combined with functional exercises)
Number of subjects: 76
Study 36457177 — intervention group
Group type: COMPARATOR
Intervention: Conventional training group (CTG) (resistance and aerobic exercise)
Number of subjects: 76
Study 36457177 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (respiratory physiotherapy)
Number of subjects: 76
Study 34088224 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture with 10 mW at LI4 bilaterally (AG)
Number of subjects: 96
Study 34088224 — intervention group
Group type: COMPARATOR
Intervention: 30% oral glucose solution (GG)
Number of subjects: 96
Study 32865148 — intervention group
Group type: EXPERIMENTAL
Intervention: PST-Hospice (Brief Problem-Solving Therapy)
Number of subjects: 37
Study 32865148 — intervention group
Group type: COMPARATOR
Intervention: UC + CE (Usual Care plus Caregiver Education)
Number of subjects: 37
Study 36401749 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on Celecoxib 400 mg/day
Number of subjects: 109
Study 36401749 — intervention group
Group type: COMPARATOR
Intervention: Add-on placebo
Number of subjects: 109
Study 33535776 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-day risk-standardized mortality rates following isolated CABG surgery
Number of subjects: 137819
Study 33535776 — intervention group
Group type: COMPARATOR
Intervention: Society of Thoracic Surgeons composite star ratings
Number of subjects: 137819
Study 34363315 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional printed anatomical models (3DP)
Number of subjects: 63
Study 34363315 — intervention group
Group type: COMPARATOR
Intervention: Plastinated human specimens
Number of subjects: 63
Study 34673326 — intervention group
Group type: EXPERIMENTAL
Intervention: TCT (Targeted Cognitive Training)
Number of subjects: 52
Study 34673326 — intervention group
Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 52
Study 34047921 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus study interventions (N = 3490)
Number of subjects: 4653
Study 34047921 — intervention group
Group type: COMPARATOR
Intervention: Usual care (N = 1163)
Number of subjects: 4653
Study 33478570 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver needle therapy (SNT) and physiotherapy
Number of subjects: 100
Study 33478570 — intervention group
Group type: COMPARATOR
Intervention: Control group (physiotherapy alone)
Number of subjects: 100
Study 33478570 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver needle therapy (SNT)
Number of subjects: 100
Study 33070152 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 10 mg/kg/day for 1 day or 2 days
Number of subjects: 180
Study 33070152 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 180
Study 33070152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 32462483 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surfactant therapy (MIST)
Number of subjects: 58
Study 32462483 — intervention group
Group type: COMPARATOR
Intervention: InSurE (intubate surfactant extubate)
Number of subjects: 58
Study 36881665 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 8
Study 36881665 — intervention group
Group type: EXPERIMENTAL
Intervention: FFP2 respirator
Number of subjects: 8
Study 36881665 — intervention group
Group type: COMPARATOR
Intervention: No mask
Number of subjects: 8
Study 34618982 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 free carboxylic acids (OM-3CA) 4 g per day
Number of subjects: 0
Study 34618982 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg per day
Number of subjects: 0
Study 34618982 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 0
Study 35749440 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth behaviour intervention (3 times per week for 12 weeks, including home-based exercise twice a week and individual lifestyle program once a week)
Number of subjects: 60
Study 35749440 — intervention group
Group type: COMPARATOR
Intervention: General health recommendations and advice for unsupervised walking training (Control group)
Number of subjects: 60
Study 35749440 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth behaviour intervention
Number of subjects: 60
Study 32950502 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35292919 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, 2%, applied twice daily for 28 days.
Number of subjects: 1313
Study 35292919 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control), applied twice daily for 28 days.
Number of subjects: 1313
Study 37830397 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed 1,064-nm gallium arsenide (GaAs) laser surgical device
Number of subjects: 20
Study 37830397 — intervention group
Group type: COMPARATOR
Intervention: Short-pulsed Nd:YAG laser surgical device
Number of subjects: 20
Study 32564459 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-layer closure (SIMULAC-I)
Number of subjects: 225
Study 32564459 — intervention group
Group type: COMPARATOR
Intervention: Single superficial-layer closure (SIMULAC-II)
Number of subjects: 225
Study 32476162 — intervention group
Group type: EXPERIMENTAL
Intervention: Eflapegrastim 13.2 mg (3.6 mg G-CSF)
Number of subjects: 406
Study 32476162 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg G-CSF
Number of subjects: 406
Study 32476162 — intervention group
Group type: EXPERIMENTAL
Intervention: Eflapegrastim
Number of subjects: 406
Study 33958268 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day for 14 weeks
Number of subjects: 84
Study 35195692 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir/emtricitabine/dolutegravir
Number of subjects: 37
Study 35195692 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir/emtricitabine/darunavir/cobicistat
Number of subjects: 37
Study 36396460 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Participation (GP) intervention
Number of subjects: 34
Study 36396460 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study 35594631 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated fish oil (FO) 3 g/d
Number of subjects: 61
Study 35594631 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (CO) 3 g/d
Number of subjects: 61
Study 33293689 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV with helmet
Number of subjects: 59
Study 35229616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy after 1 month (with aspirin for the first month)
Number of subjects: 15968
Study 35229616 — intervention group
Group type: COMPARATOR
Intervention: Standard dual antiplatelet therapy for 1 year followed by aspirin alone
Number of subjects: 15968
Study 35229616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 15968
Study 35229616 — intervention group
Group type: COMPARATOR
Intervention: Standard dual antiplatelet therapy
Number of subjects: 15968
Study 32688047 — intervention group
Group type: EXPERIMENTAL
Intervention: Power posing (holding powerful postures)
Number of subjects: 150
Study 32688047 — intervention group
Group type: COMPARATOR
Intervention: Neutral postures (control group)
Number of subjects: 150
Study 35481945 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric Muscle Stimulation (EMS) warm-up
Number of subjects: 12
Study 35481945 — intervention group
Group type: COMPARATOR
Intervention: Control warm-up
Number of subjects: 12
Study 33762196 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (Group-K, n=52): 1mg/kg ketamine in 20mL saline
Number of subjects: 102
Study 33762196 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group-S, n=50): 20mL saline
Number of subjects: 102
Study 33762196 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group-S, n=50)
Number of subjects: 102
Study 33762196 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (Group-K, n=52)
Number of subjects: 102
Study 33762196 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (Group-K, n=52) and Saline (Group-S, n=50)
Number of subjects: 102
Study 32341582 — intervention group
Group type: EXPERIMENTAL
Intervention: ChemoCalc software
Number of subjects: 20
Study 34699270 — intervention group
Group type: EXPERIMENTAL
Intervention: Pop-up book about anesthesia
Number of subjects: 148
Study 34699270 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 148
Study 33961944 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic models (R-model, C-model, E-model, Integ-model) derived from coronary computed tomography angiography (CCTA)
Number of subjects: 161
Study 32675261 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive opioid reduction protocol
Number of subjects: 186
Study 32675261 — intervention group
Group type: COMPARATOR
Intervention: Crossover intervention applied to original control group
Number of subjects: 186
Study 35240925 — intervention group
Group type: EXPERIMENTAL
Intervention: Typhoid Conjugate Vaccine (TCV)
Number of subjects: 20000
Study 35240925 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine
Number of subjects: 20000
Study 32867541 — intervention group
Group type: EXPERIMENTAL
Intervention: Impersonal educative news articles featuring interviews with suicide prevention experts (two versions: one emphasizing prevention, the other emphasizing prevalence)
Number of subjects: 425
Study 32867541 — intervention group
Group type: COMPARATOR
Intervention: Control group (article unrelated to suicide)
Number of subjects: 425
Study 34187937 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular Nerve Block (SSNB) with 10ml of 0.5% Bupivacaine
Number of subjects: 86